UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048354
Receipt number R000055071
Scientific Title Changes and related factors in the circadian activity rhythm and temperature rhythm after discharge from rehabilitation facility
Date of disclosure of the study information 2022/07/20
Last modified on 2022/07/12 15:23:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Changes and related factors in the circadian activity rhythm and temperature rhythm after discharge from rehabilitation facility

Acronym

Changes and related factors in the circadian activity rhythm and temperature rhythm after discharge

Scientific Title

Changes and related factors in the circadian activity rhythm and temperature rhythm after discharge from rehabilitation facility

Scientific Title:Acronym

Changes and related factors in the circadian activity rhythm and temperature rhythm after discharge

Region

Japan


Condition

Condition

stroke, motor diseases

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the circadian activity rhythm and temperature rhythm of patients during hospitalization and after discharge

Basic objectives2

Others

Basic objectives -Others

prevention

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Patients were evaluated one week after admission.
Primary outcomes were the amount of activity and temperature of inpatient.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients were treated at the rehabilitation facility in Japan
2. Sixty-five years of age or more
3. Diagnosed to have stroke or motor diseases
4.No signs of cognitive decline, as determined by the Mini-Mental State Examination, which had a cut-off value of >23

Key exclusion criteria

1.Patients not permitted to participate in the study by their doctors due to risks associated with assessing mental and physical function
2.With severe memory impairment or aphasia
3.Diagnosed with arteriosclerosis obliterans
4. have a metal allergy

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yuki
Middle name
Last name Nakagawa

Organization

(1)Osaka University of Human Sciences, Japan
(2)Graduate School of Health Sciences, Kobe University, Kobe, Japan

Division name

(1)Faculty of Health Sciences(2)Department of Rehabilitation Science

Zip code

566-8501

Address

(1)1-4-1 Shojaku, Settsu-shi, Osaka (2)7-10-2 Tomogaoka Suma-ku, Kobe-shi, Hyogo-ken, Japan

TEL

06-6383-6441

Email

yuki-nakagawa@kun.ohs.ac.jp


Public contact

Name of contact person

1st name Yuki
Middle name
Last name Nakagawa

Organization

Osaka University of Human Sciences, Japan

Division name

Faculty of Health Sciences

Zip code

566-8501

Address

1-4-1 Shojaku, Settsu-shi, Osaka

TEL

06-6383-6441

Homepage URL


Email

yuki-nakagawa@kun.ohs.ac.jp


Sponsor or person

Institute

Osaka University of Human Sciences

Institute

Department

Personal name



Funding Source

Organization

Graduate School of Health Sciences, Kobe University, Kobe, Japan

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Senri-chuo Hospital, Japan

Name of secondary funder(s)



IRB Contact (For public release)

Organization

the ethics committee of Senri-chuo Hospital

Address

1-4-3 Sinsenrihigashi-machi, Toyonaka-shi, Osakahu, Japan

Tel

06-6834-1100

Email

naritomi@kyowakai.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

34

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

I will submit the results to a paper. Therefore, I can not publish the results.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 10 Month 01 Day

Date of IRB

2019 Year 10 Month 01 Day

Anticipated trial start date

2019 Year 10 Month 01 Day

Last follow-up date

2020 Year 05 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Inpatients admitted to the rehabilitation unit in A hospital who met the inclusion criteria were selected.


Management information

Registered date

2022 Year 07 Month 12 Day

Last modified on

2022 Year 07 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055071